Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05486546 · ClinicalTrials.gov registry record · NA
Contoura With Phorcides Compared to Wavefront Optimized LASIK
A NA study of Myopia and Astigmatism, sponsored by Daniel Terveen.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 4
- Study locations
NCT05486546 is a NA study of Myopia and Astigmatism that is actively recruiting participants, run by Daniel Terveen. The registered enrollment target is 120 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (55% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT05486546, a NA study of Myopia and Astigmatism, is actively recruiting participants, sponsored by Daniel Terveen.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 4
- Study locations
Study Summary
Comparing post-operative visual acuity and patient reported satisfaction between Contoura with Phorcides and WaveLight Wavefront Optimized.
Conditions Studied
Interventions
- PROCEDURE Contoura with Phorcides
- DEVICE WaveLight Wavefront Optimized
Study Locations (4)
Montana
- Vance Thompson Vison - Bozeman
Nebraska
- Vance Thompson Vision - Omaha
North Dakota
- Vance Thompson Vision - Fargo
South Dakota
- Vance Thompson Vision - Sioux Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2022-08-15 |
| Est. Completion | 2023-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05486546
The ClinicalTrials.gov registry entry for NCT05486546 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (55% lower). The listed sponsor is Daniel Terveen, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Contoura with Phorcides is the first listed.
NCT05486546 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Montana, Nebraska, North Dakota.
Frequently Asked Questions
What is clinical trial NCT05486546 about?
NCT05486546 is a clinical study titled "Contoura With Phorcides Compared to Wavefront Optimized LASIK". Comparing post-operative visual acuity and patient reported satisfaction between Contoura with Phorcides and WaveLight Wavefront Optimized.
What is the current status of trial NCT05486546?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2022-08-15. Estimated completion is 2023-12-01.
What conditions does trial NCT05486546 study?
This clinical trial studies the following conditions: Myopia, Astigmatism.
What interventions are being tested in trial NCT05486546?
The interventions under investigation include: Contoura with Phorcides (PROCEDURE), WaveLight Wavefront Optimized (DEVICE).
Who is sponsoring clinical trial NCT05486546?
This trial is sponsored by Daniel Terveen, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05486546 being conducted?
This trial has 4 study locations across Montana, Nebraska, North Dakota, South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.